Articles by Patricia Van Arnum - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Patricia Van Arnum

Gauging Investment in High-Potency Manufacturing

Contract service providers expand capabilities in API and finished product manufacturing to meet demand for high-potency drugs
Aug 7, 2013

Contract service providers expand capabilities in API and finished product manufacturing to meet demand for high-potency drugs

Pfizer, Merck, Sanofi, and AstraZeneca Facing the Generic-Drug Squeeze

Pfizer, Merck, Sanofi, and AstraZeneca are among the companies reporting revenue declines from generic-drug incursion. A look at what the companies are doing to stimulate growth.
Aug 7, 2013

Pfizer, Merck, Sanofi, and AstraZeneca are among the companies reporting revenue declines from generic-drug incursion. A look at what the companies are doing to stimulate growth.

Evaluating the Pieces in Big Pharma's Manufacturing Investments

The pharmaceutical majors target biologics and emerging markets in their manufacturing expansion activities and plans.
Aug 2, 2013

The pharmaceutical majors target biologics and emerging markets in their manufacturing expansion activities and plans.

Advancing Peptide Synthesis Through Stapled Peptides

Stapled peptides offer promise to enable cell permeability, binding to therapeutic targets, and modulation of biological pathways.
Aug 2, 2013

Stapled peptides offer promise to enable cell permeability, binding to therapeutic targets, and modulation of biological pathways.

Defining Quality Agreements

Recent draft guidance from FDA on contract manufacturing and quality agreements highlights the importance of such agreements and define the roles and responsibilities of each party.
Aug 1, 2013

Recent draft guidance from FDA on contract manufacturing and quality agreements highlights the importance of such agreements and define the roles and responsibilities of each party to be in keeping with quality risk-management principles.

A Shifting Landscape for the Global API Market

API demand and supply reflect broader pharma trends.
Aug 1, 2013

External manufacturing plays a crucial role in pharmaceutical companies’ supply strategy. The author examines market trends for the captive and merchant global market for active pharmaceutical ingredients and intermediates.

Tracking the Expansion Activities of Contract Service Providers

A review of recent moves of CDMOs and CMOs
Aug 1, 2013

The investment activity of CDMOs and CMOs reveals the broader business and technical trends of the pharmaceutical industry.

Evaluating China's Supply Chain

Increased pharmaceutical trade creates new challenges for regulatory oversight.
Aug 1, 2013

Increased pharmaceutical trade creates new challenges for regulatory oversight.

Strengthening the Supply Chain for Pharmaceutical Ingredients

The US and EU move forward with measures to fortify the pharmaceutical supply chain.
Jul 10, 2013

The US and EU move forward with measures to fortify the pharmaceutical supply chain.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
9%
All of the above.
45%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here